Replies to post #42536 on Endexx Corp (EDXC)

[neophyte184]

There is no doubt that it does. And given what will likely happen in terms of the regulatory structure once cannabis is rescheduled to a II, those companies exhibiting clinical trials with positive outcomes are the ones most likely to get snapped up by big Pharma… You know what that means. ;-)


EDXC